Actively Recruiting

Phase 2
All Genders
NCT06761170

Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS)

Led by Beth Israel Deaconess Medical Center · Updated on 2025-07-28

50

Participants Needed

1

Research Sites

84 weeks

Total Duration

On this page

Sponsors

B

Beth Israel Deaconess Medical Center

Lead Sponsor

A

American Association of Broncology and Interventional Pulmonology

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare spray cryotherapy plus balloon dilatation versus current standard of Care (SoC - steroid injection, radial cuts and balloon dilatation) in patients with benign airway stenosis with simple stenosis. The main question\[s\] investigators aim to answer are: 1. What is the need for reintervention and time to reintervention in participants with benign airway stenosis with simple stenosis who receive spray cryotherapy plus balloon dilatation versus standard of care alone? 2. To evaluate patient experience, physiological, anatomical changes, health care utilization and safety of the SCT plus balloon dilatation versus standard of care alone. Researchers will compare spray cryotherapy plus balloon dilatation versus current standard of Care (SoC - steroid injection, radial cuts and balloon dilatation) in patients with benign airway stenosis with simple stenosis to see if it reduces the need of re intervention. Participants will surgery and receive one of the two interventions.

CONDITIONS

Official Title

Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with symptomatic, benign, simple stenosis of the trachea and/or subglottic space.
  • Stenotic airway diameter less than 1 cm.
Not Eligible

You will not qualify if you...

  • Complex stenosis or cartilage involvement such as malacia or fracture.
  • Presence of giant bullae larger than one third of the hemithorax or bullae greater than 3 cm.
  • Concurrent tracheoesophageal fistula or active tracheal malignancy.
  • Presence of other upper airway obstruction.
  • Pregnancy.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

C

Christine Conley

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here